Depression relapse. Venlafaxine was superior to lithium in reducing symptoms of both bipolar II, depression, and anxiety. According to the results of a recent study published in the Journal of ...

PITTSBURGH and TOKYO, Oct. 9, 2024 /PRNewswire/ -- Viatris Inc. (VTRS) (NASDAQ: VTRS), a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japan ...

Aiming to address a significant unmet need for which no other approved treatment option is available for generalized anxiety disorder patients in Japan As previously announced, our Phase 3 ...

(RTTNews) - Viatris Inc. (VTRS), a healthcare company, Monday said it has submitted Supplemental New Drug Application to Japan's Ministry of Health, Labor and Welfare (MHLW) for Effexor to treat ...

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

Generic and biosimilar drugs are often preferred over the brand name version due to their cheaper prices. Generics are exact ...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has acquired Aculys Pharma, Inc., a clinical stage biopharmaceutical company focused on commercializing innovative ...

Aiming to address a significant unmet need for which no other approved treatment option is available for generalized anxiety disorder patients in Japan "The filing of our supplemental New Drug ...